OptionsHouse

Options Trading News

September 27, 2013  Fri 7:26 AM CT

NKE: SEE CHART GET CHAIN FIND STRATEGIES

Lower Costs Boost Margins

Nike earned $0.86 a share in its first quarter, beating the $0.78 average analyst estimate. Revenue of $6.97 billion also exceeded the $6.96 billion consensus number. Management said lower input costs and reduced discounting boosted margins. Orders remain strong as well. NKE rallies 6 percent before the opening bell on my tradeMONSTER platform.

Finish Line Earnings, Sales Beat Consensus

Finish Line reported second-quarter net income of $0.54 on sales of $436 million. Analysts had only expected $0.45 and $426.4 million, respectively. Management also raised its full-year guidance for comparable sales. FINL climbs 9 percent in the premarket.

Nektar Tanks on Drug Trial Disappointment

Nektar Therapeutics announced that its NKTR-181 painkiller failed to meet its primary endpoint in a Phase 2 study. NKTR sinks 22 percent in early trading.

Share this article with your friends


OptionsHouse

Premium Services

Upcoming Webinar:

How to Defend Your Portfolio and Profit in a Market Selloff

http://bit.ly/1OSMWU6

Jon Najarian and Sandy Chaikin of Chaikin Analytics demonstrate how to play defense when the market is selling off. And, how to turn misery into money, whether investing in stocks or trading options.

Education & Strategy

The sweet spot

When using the Stock Replacement Strategy, we must remember that in reality, we are doing a STOCK trade. We are just using options. We are replacing the stock position with an option position (long calls).

View more education articles »